{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:36:03Z","timestamp":1780472163392,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Serious mental illnesses, such as schizophrenia, schizoaffective or bipolar disorder, often starts in late teens or twenties. Adherence to antipsychotic treatment for serious mental illness is often poor. Involving service users in decisions about their treatment leads to improved clinical outcomes and adherence. Shared decision-making is bilateral information sharing between clinician and service user where decision-making is shared between both parties. This study aimed to evaluate the lived experiences of young adults on how healthcare professionals involve them in decisions about antipsychotic medication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Fifteen semi-structured interviews were conducted online using Zoom. Participants were selected using purposive sampling via patient recruitment platform, support groups relevant to psychosis and social media. Those included in the study were diagnosed with schizophrenia, schizoaffective or bipolar disorder and treated with antipsychotics between the ages of 18\u201330. Data was coded inductively and thematic analysis was used to analyse the data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four themes were identified. These were living with antipsychotics, influence of family and friends, gaining autonomy and consequences of young adulthood. Findings highlighted the range of side effects from antipsychotic medication and their impact on young adults, and how the choices made by health care professionals influenced the quality of shared decision-making. Health care professionals\u2019 decisions directly influence the quality of life for service users. Young adults with psychosis acknowledge the effectiveness of antipsychotics but see the side effects as significant obstacles in their lives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The study found that health care professionals provided limited acknowledgement and support for antipsychotic side effects, which significantly impacted the young adults\u2019 lives. Young adults want to be fully informed of their medication and potential side effects but support from friends and family was a potential barrier. Changes in practice are needed including an adjustment in clinical language used by health care professionals, giving information to service users\u2019 post-psychosis and ensuring health care professionals are trained in shared decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11096-026-02090-7","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:52:09Z","timestamp":1771933929000},"page":"949-959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lived experiences of shared decision-making in young adults prescribed antipsychotics: a qualitative interview study"],"prefix":"10.1007","volume":"48","author":[{"given":"Holly","family":"Grey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8586-0231","authenticated-orcid":false,"given":"Laura","family":"Lindsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"2","key":"2090_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-019-0997-0","volume":"21","author":"J Rehm","year":"2019","unstructured":"Rehm J, Shield KD. Global burden of disease and the impact of mental and addictive disorders. Curr Psychiatry Rep. 2019;21(2):10.","journal-title":"Curr Psychiatry Rep"},{"key":"2090_CR2","unstructured":"National Health Service. Adult psychiatric morbidity survey: survey of mental health and wellbeing, England, 2014. 2014."},{"issue":"1","key":"2090_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","volume":"27","author":"M Solmi","year":"2022","unstructured":"Solmi M, Radua J, Olivola M, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of\u00a0192 epidemiological studies. Mol Psychiatry. 2022;27(1):281\u201395.","journal-title":"Mol Psychiatry"},{"key":"2090_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102294","author":"JKN Chan","year":"2023","unstructured":"Chan JKN, Correll CU, Wong CSM, et al. Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis. eClinicalMedicine. 2023. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102294.","journal-title":"eClinicalMedicine"},{"issue":"1","key":"2090_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","volume":"125","author":"GP Reynolds","year":"2010","unstructured":"Reynolds GP, Kirk SL. Metabolic side effects of antipsychotic drug treatment-pharmacological mechanisms. Pharmacol Ther. 2010;125(1):169\u201379.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"2090_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/wps.20128","volume":"13","author":"E Chesney","year":"2014","unstructured":"Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014;13(2):153\u201360.","journal-title":"World Psychiatry"},{"issue":"1","key":"2090_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1600-0447.2009.01425.x","volume":"121","author":"H Verdoux","year":"2010","unstructured":"Verdoux H, Tournier M, B\u00e9gaud B. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand. 2010;121(1):4\u201310.","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"2090_CR8","first-page":"31","volume":"4","author":"K-M Haapasalo-Pesu","year":"2016","unstructured":"Haapasalo-Pesu K-M, Karukivi M, Saarij\u00e4rvi S. The growing trend of prescribing antipsychotics for young people in Finland, 2000 to 2010. Scand J Child Adolesc Psychiatr Psychol. 2016;4(1):31\u20135.","journal-title":"Scand J Child Adolesc Psychiatr Psychol"},{"key":"2090_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105454","volume":"155","author":"RTS Chow","year":"2023","unstructured":"Chow RTS, Whiting D, Favril L, et al. An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs. Neurosci Biobehav Rev. 2023;155:105454.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"2090_CR10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1365-2648.2008.04906.x","volume":"65","author":"TV McCann","year":"2009","unstructured":"McCann TV, Clark E, Lu S. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia. J Adv Nurs. 2009;65(3):534\u201343.","journal-title":"J Adv Nurs"},{"issue":"4","key":"2090_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1177\/0269881114562090","volume":"29","author":"SL Young","year":"2015","unstructured":"Young SL, Taylor M, Lawrie SM. \u201cFirst do no harm.\u201d A systematic review of the prevalence and management of antipsychotic adverse effects. J Psychopharmacol. 2015;29(4):353\u201362.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"2090_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/wps.20567","volume":"17","author":"TS Stroup","year":"2018","unstructured":"Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry. 2018;17(3):341\u201356.","journal-title":"World Psychiatry"},{"issue":"4","key":"2090_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.1440-0979.2000.00181.x","volume":"9","author":"P Morrison","year":"2000","unstructured":"Morrison P, Gaskill D, Meehan T, et al. The use of the Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) in clinical practice. Aust N Z J Ment Health Nurs. 2000;9(4):166\u201376.","journal-title":"Aust N Z J Ment Health Nurs"},{"issue":"12","key":"2090_CR14","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209\u201323.","journal-title":"N Engl J Med"},{"issue":"10","key":"2090_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/gps.1777","volume":"22","author":"M Sajatovic","year":"2007","unstructured":"Sajatovic M, Blow FC, Kales HC, et al. Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder. Int J Geriatr Psychiatry. 2007;22(10):992\u20138.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"6","key":"2090_CR16","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1177\/1039856217734711","volume":"25","author":"V Alguera-Lara","year":"2017","unstructured":"Alguera-Lara V, Dowsey MM, Ride J, et al. Shared decision making in mental health: the importance for current clinical practice. Australas Psychiatry. 2017;25(6):578\u201382.","journal-title":"Australas Psychiatry"},{"issue":"5","key":"2090_CR17","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2021.987","volume":"7","author":"Y Zisman-Ilani","year":"2021","unstructured":"Zisman-Ilani Y, Chmielowska M, Dixon LB, et al. NICE shared decision making guidelines and mental health: challenges for research, practice and implementation. BJPsych Open. 2021;7(5):e154.","journal-title":"BJPsych Open"},{"issue":"5","key":"2090_CR18","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s11096-016-0352-z","volume":"38","author":"M Younas","year":"2016","unstructured":"Younas M, Bradley E, Holmes N, et al. Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness. Int J Clin Pharm. 2016;38(5):1191\u20139.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"2090_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/17522439.2021.1903979","volume":"13","author":"LM Gr\u00fcnwald","year":"2021","unstructured":"Gr\u00fcnwald LM, Thompson J. Re-starting the conversation: improving shared decision making in antipsychotic prescribing. Psychosis. 2021;13(4):373\u20137.","journal-title":"Psychosis"},{"key":"2090_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-14-127","volume":"14","author":"A Shepherd","year":"2014","unstructured":"Shepherd A, Shorthouse O, Gask L. Consultant psychiatrists\u2019 experiences of and attitudes towards shared decision making in antipsychotic prescribing, a qualitative study. BMC Psychiatry. 2014;14:127.","journal-title":"BMC Psychiatry"},{"issue":"4","key":"2090_CR21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/schbul\/sbaa002","volume":"46","author":"J Read","year":"2020","unstructured":"Read J, Sacia A. Using open questions to understand 650 people\u2019s experiences with antipsychotic drugs. Schizophr Bull. 2020;46(4):896\u2013904.","journal-title":"Schizophr Bull"},{"key":"2090_CR22","volume-title":"National summary of the results for the 2013 community mental health survey","author":"Care Quality Commission","year":"2013","unstructured":"Care Quality Commission. National summary of the results for the 2013 community mental health survey. London: CQC; 2013."},{"issue":"5","key":"2090_CR23","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s11096-023-01630-9","volume":"45","author":"J Howe","year":"2023","unstructured":"Howe J, Lindsey L. The role of pharmacists in supporting service users to optimise antipsychotic medication. Int J Clin Pharm. 2023;45(5):1293\u20138.","journal-title":"Int J Clin Pharm"},{"issue":"6","key":"2090_CR24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1017\/neu.2014.21","volume":"26","author":"C De las Cuevas","year":"2014","unstructured":"De las Cuevas C, Pe\u00f1ate W. To what extent psychiatric patients feel involved in decision making about their mental health care? Relationships with socio-demographic, clinical, and psychological variables. Acta Neuropsychiatr. 2014;26(6):372\u201381.","journal-title":"Acta Neuropsychiatr"},{"issue":"4","key":"2090_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/1742395317694223","volume":"13","author":"K Harris","year":"2017","unstructured":"Harris K, Brooks H, Lythgoe G, et al. Exploring service users\u2019, carers\u2019 and professionals\u2019 perspectives and experiences of current antipsychotic prescribing: a qualitative study. Chronic Illn. 2017;13(4):275\u201387.","journal-title":"Chronic Illn"},{"issue":"2","key":"2090_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s11414-014-9431-x","volume":"42","author":"J Delman","year":"2015","unstructured":"Delman J, Clark JA, Eisen SV, et al. Facilitators and barriers to the active participation of clients with serious mental illnesses in medication decision making: the perceptions of young adult clients. J Behav Health Serv Res. 2015;42(2):238\u201353.","journal-title":"J Behav Health Serv Res"},{"issue":"1","key":"2090_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12888-019-2304-3","volume":"19","author":"SJ Kaar","year":"2019","unstructured":"Kaar SJ, Gobjila C, Butler E, et al. Making decisions about antipsychotics: a qualitative study of patient experience and the development of a decision aid. BMC Psychiatry. 2019;19(1):309.","journal-title":"BMC Psychiatry"},{"issue":"6","key":"2090_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"issue":"12","key":"2090_CR29","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1111\/jan.13031","volume":"72","author":"H Kallio","year":"2016","unstructured":"Kallio H, Pietil\u00e4 A-M, Johnson M, et al. Systematic methodological review: developing a framework for a qualitative semi-structured interview guide. J Adv Nurs. 2016;72(12):2954\u201365.","journal-title":"J Adv Nurs"},{"issue":"2","key":"2090_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"2090_CR31","volume-title":"Successful qualitative research: a practical guide for beginners","author":"V Clarke","year":"2013","unstructured":"Clarke V, Braun V. Successful qualitative research: a practical guide for beginners. London: Sage; 2013."},{"issue":"1","key":"2090_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-128","volume":"11","author":"A Sbaraini","year":"2011","unstructured":"Sbaraini A, Carter SM, Evans RW, et al. How to do a grounded theory study: a worked example of a study of dental practices. BMC Med Res Methodol. 2011;11(1):128.","journal-title":"BMC Med Res Methodol"},{"key":"2090_CR33","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/hex.13724","volume":"26","author":"D Ridge","year":"2023","unstructured":"Ridge D, Bullock L, Causer H, et al. \u201cImposter participants\u201d in online qualitative research, a new and increasing threat to data integrity? Health Expect. 2023;26:941\u20134.","journal-title":"Health Expect"},{"key":"2090_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-6-42","volume":"6","author":"J Helbling","year":"2006","unstructured":"Helbling J, Ajdacic-Gross V, Lauber C, et al. Attitudes to antipsychotic drugs and their side effects: a comparison between general practitioners and the general population. BMC Psychiatry. 2006;6:42.","journal-title":"BMC Psychiatry"},{"issue":"5","key":"2090_CR35","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/jpm.12600","volume":"27","author":"F Begum","year":"2020","unstructured":"Begum F, Mutsatsa S, Gul N, et al. Antipsychotic medication side effects knowledge amongst registered mental health nurses in England: a national survey. J Psychiatr Ment Health Nurs. 2020;27(5):521\u201332.","journal-title":"J Psychiatr Ment Health Nurs"},{"issue":"2","key":"2090_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-042497","volume":"11","author":"A Nash","year":"2021","unstructured":"Nash A, Kingstone T, Farooq S, et al. Switching antipsychotics to support the physical health of people with severe mental illness: a qualitative study of healthcare professionals\u2019 perspectives. BMJ Open. 2021;11(2):e042497.","journal-title":"BMJ Open"},{"key":"2090_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1192\/bjp.bp.114.155945","volume":"206","author":"M Taylor","year":"2015","unstructured":"Taylor M, Perera U. NICE CG178 Psychosis and Schizophrenia in Adults: Treatment and Management\u2014An evidence-based guideline? Br J Psychiatry. 2015;206:357\u20139.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"2090_CR38","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1186\/s12913-020-05949-1","volume":"20","author":"EW Haugom","year":"2020","unstructured":"Haugom EW, Stensrud B, Beston G, et al. Mental health professionals\u2019 experiences with shared decision-making for patients with psychotic disorders: a qualitative study. BMC Health Serv Res. 2020;20(1):1093.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"2090_CR39","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1186\/s12888-023-05257-y","volume":"23","author":"EW Haugom","year":"2023","unstructured":"Haugom EW, Benth J, Stensrud B, et al. Shared decision making and associated factors among patients with psychotic disorders: a cross-sectional study. BMC Psychiatry. 2023;23(1):747.","journal-title":"BMC Psychiatry"},{"key":"2090_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n727","volume":"372","author":"A Beck","year":"2021","unstructured":"Beck A, Farmer P, Wykes T. Proposed reforms of the mental health act. BMJ. 2021;372:n727.","journal-title":"BMJ"},{"key":"2090_CR41","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.psychres.2016.04.042","volume":"243","author":"A Kaushik","year":"2016","unstructured":"Kaushik A, Kostaki E, Kyriakopoulos M. The stigma of mental illness in children and adolescents: a systematic review. Psychiatry Res. 2016;243:469\u201394.","journal-title":"Psychiatry Res"},{"key":"2090_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/PRBM.S243722","volume":"13","author":"HT Jameel","year":"2020","unstructured":"Jameel HT, Panatik SA, Nabeel T, et al. Observed social support and willingness for the treatment of patients with schizophrenia. Psychol Res Behav Manag. 2020;13:193\u2013201.","journal-title":"Psychol Res Behav Manag"},{"issue":"5","key":"2090_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.11622\/smedj.2021057","volume":"62","author":"HS Ong","year":"2021","unstructured":"Ong HS, Fernandez PA, Lim HK. Family engagement as part of managing patients with mental illness in primary care. Singapore Med J. 2021;62(5):213\u20139.","journal-title":"Singapore Med J"},{"issue":"9","key":"2090_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2025-103146","volume":"15","author":"C Hynes-Ryan","year":"2025","unstructured":"Hynes-Ryan C, Kelleher I, Kathryn S, et al. Youth Med.Info: a case study in co-design of mental health medicines-information resources for children, young people and their parents\/guardians. BMJ Open. 2025;15(9):e103146.","journal-title":"BMJ Open"},{"issue":"10","key":"2090_CR45","doi-asserted-by":"publisher","first-page":"10967","DOI":"10.3390\/ijerph111010967","volume":"11","author":"M Rubio-Valera","year":"2014","unstructured":"Rubio-Valera M, Chen TF, O\u2019Reilly CL. New roles for pharmacists in community mental health care: a narrative review. Int J Environ Res Public Health. 2014;11(10):10967\u201390.","journal-title":"Int J Environ Res Public Health"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02090-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-026-02090-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-026-02090-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:04:53Z","timestamp":1778749493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-026-02090-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2090"],"URL":"https:\/\/doi.org\/10.1007\/s11096-026-02090-7","relation":{},"ISSN":["2210-7711"],"issn-type":[{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"2 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study received ethical approval from Newcastle University\u2019s Faculty of Medical Sciences Ethics Committee on 22nd of October 2024 (Ref No. 2935\/52133).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants gave written and verbal consent for participation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}